Associated Papers
Galactose mutarotase deficiency as the galactosemia type IV.
Wada Y et al.
Journal of Human Genetics, 2025
Rethinking Newborn Screening: A Case of GALM Deficiency.
van Konijnenburg EMMH et al.
International Journal of Neonatal Screening, 2025
Clinical and biochemical evolution after partial dietary liberalization of two cases of galactosemia due to galactose mutarotase deficiency.
Sánchez-Pintos P et al.
Bmc Pediatrics, 2024
Phenotypic and genetic spectra of galactose mutarotase deficiency: A nationwide survey conducted in Japan.
Mikami-Saito Y et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2024
Comprehensive analysis of non-synonymous missense SNPs of human galactose mutarotase (GALM) gene: an integrated computational approach.
Murthy TPK et al.
Journal of Biomolecular Structure & Dynamics, 2023
Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment.
Succoio M et al.
Biomolecules, 2022
The Discovery of GALM Deficiency (Type IV Galactosemia) and Newborn Screening System for Galactosemia in Japan.
Kikuchi A et al.
International Journal of Neonatal Screening, 2021
Evolutionary history of human colitis-associated colorectal cancer.
Baker AM et al.
Gut, 2019
29991641 (PubMed )
Supplement: gutjnl-2018-316191supp005.xlsx › UC06
Biallelic GALM pathogenic variants cause a novel type of galactosemia.
Wada Y et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2019
Type IV galactosemia.
Timson DJ
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2019
The prevalence of GALM mutations that cause galactosemia: A database of functionally evaluated variants.
Iwasawa S et al.
Molecular Genetics and Metabolism, 2019
Select a paper to view details